APA (7th ed.) Citation

Aderhold, M. C., Lammert, A., Umbreit, C., Birk, R., Weiß, C., Sommer, U., . . . Schultz, J. D. (2015). Targeting mTOR and AREG with Everolimus, Sunitinib and Sorafenib in HPV-positive and -negative SCC. Anticancer research, 35(4), .

Chicago Style (17th ed.) Citation

Aderhold, Marc Christoph, Anne Lammert, Claudia Umbreit, Richard Birk, Christel Weiß, Ulrich Sommer, Karl Hörmann, and Johannes D. Schultz. "Targeting MTOR and AREG with Everolimus, Sunitinib and Sorafenib in HPV-positive and -negative SCC." Anticancer Research 35, no. 4 (2015).

MLA (9th ed.) Citation

Aderhold, Marc Christoph, et al. "Targeting MTOR and AREG with Everolimus, Sunitinib and Sorafenib in HPV-positive and -negative SCC." Anticancer Research, vol. 35, no. 4, 2015.